DK394576A - - Google Patents

Info

Publication number
DK394576A
DK394576A DK394576A DK394576A DK394576A DK 394576 A DK394576 A DK 394576A DK 394576 A DK394576 A DK 394576A DK 394576 A DK394576 A DK 394576A DK 394576 A DK394576 A DK 394576A
Authority
DK
Denmark
Application number
DK394576A
Other languages
Danish (da)
Other versions
DK140847C (fr
DK140847B (da
Inventor
L Nedelec
V Torelli
Fournex
Original Assignee
Roussel Uclaf S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf S A filed Critical Roussel Uclaf S A
Publication of DK394576A publication Critical patent/DK394576A/da
Publication of DK140847B publication Critical patent/DK140847B/da
Application granted granted Critical
Publication of DK140847C publication Critical patent/DK140847C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK394576AA 1975-09-02 1976-09-01 Analogifremgangsmåde til fremstilling af 2,2-dimethyl-pregn-4-en-3,20-dioner. DK140847B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7526859A FR2322606A1 (fr) 1975-09-02 1975-09-02 Nouveaux 2,2-dimethyl steroides, leur procede de preparation et leur application comme medicament

Publications (3)

Publication Number Publication Date
DK394576A true DK394576A (fr) 1977-03-03
DK140847B DK140847B (da) 1979-11-26
DK140847C DK140847C (fr) 1980-05-12

Family

ID=9159543

Family Applications (1)

Application Number Title Priority Date Filing Date
DK394576AA DK140847B (da) 1975-09-02 1976-09-01 Analogifremgangsmåde til fremstilling af 2,2-dimethyl-pregn-4-en-3,20-dioner.

Country Status (12)

Country Link
US (1) US4078059A (fr)
JP (1) JPS5233663A (fr)
BE (1) BE845740A (fr)
CA (1) CA1072540A (fr)
CH (1) CH614722A5 (fr)
DE (1) DE2639600A1 (fr)
DK (1) DK140847B (fr)
FR (1) FR2322606A1 (fr)
GB (1) GB1518864A (fr)
IE (1) IE44385B1 (fr)
LU (1) LU75698A1 (fr)
NL (1) NL7609690A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364655A1 (fr) * 1976-09-17 1978-04-14 Roussel Uclaf Nouveaux 2,2-dimethyl 19-nor steroides, leur procede de preparation et leur application comme medicament
FR2434175A1 (fr) * 1978-03-15 1980-03-21 Roussel Uclaf Nouveaux 2,2-dimethyl 19-nor steroides, leur procede de preparation et leur application comme medicaments
FR2444047A1 (fr) * 1978-12-13 1980-07-11 Roussel Uclaf Nouveaux derives 2,2-dimethyl 19-nor steroides, leur procede de preparation et leur application comme medicaments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB803777A (en) * 1955-11-16 1958-10-29 Upjohn Co Improvements in or relating to steroids and the manufacture thereof

Also Published As

Publication number Publication date
LU75698A1 (fr) 1977-06-15
CA1072540A (fr) 1980-02-26
DK140847C (fr) 1980-05-12
DK140847B (da) 1979-11-26
GB1518864A (en) 1978-07-26
US4078059A (en) 1978-03-07
IE44385L (en) 1977-03-02
IE44385B1 (en) 1981-11-04
DE2639600A1 (de) 1977-03-03
CH614722A5 (fr) 1979-12-14
JPS5233663A (en) 1977-03-14
FR2322606A1 (fr) 1977-04-01
BE845740A (fr) 1977-03-01
NL7609690A (nl) 1977-03-04
FR2322606B1 (fr) 1979-09-14

Similar Documents

Publication Publication Date Title
DK140847C (fr)
JPS5524654Y2 (fr)
JPS533013Y2 (fr)
JPS5262348U (fr)
JPS5717441Y2 (fr)
NO135505C (fr)
JPS5215982U (fr)
CH590481A5 (fr)
CH594971A5 (fr)
BG22104A1 (fr)
BG22115A1 (fr)
BG22152A1 (fr)
BG22273A1 (fr)
BG22696A1 (fr)
BG22748A1 (fr)
BG22763A1 (fr)
CH1279675A4 (fr)
CH1355175A4 (fr)
CH584348A5 (fr)
CH586393A5 (fr)
CH586397A5 (fr)
BE841787A (fr)
CH592300A5 (fr)
CH592314A5 (fr)
CH600784A5 (fr)

Legal Events

Date Code Title Description
PBP Patent lapsed